Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jan 20;469(7330):356-61.
doi: 10.1038/nature09650. Epub 2010 Dec 15.

Genetic variegation of clonal architecture and propagating cells in leukaemia

Affiliations

Genetic variegation of clonal architecture and propagating cells in leukaemia

Kristina Anderson et al. Nature. .

Abstract

Little is known of the genetic architecture of cancer at the subclonal and single-cell level or in the cells responsible for cancer clone maintenance and propagation. Here we have examined this issue in childhood acute lymphoblastic leukaemia in which the ETV6-RUNX1 gene fusion is an early or initiating genetic lesion followed by a modest number of recurrent or 'driver' copy number alterations. By multiplexing fluorescence in situ hybridization probes for these mutations, up to eight genetic abnormalities can be detected in single cells, a genetic signature of subclones identified and a composite picture of subclonal architecture and putative ancestral trees assembled. Subclones in acute lymphoblastic leukaemia have variegated genetics and complex, nonlinear or branching evolutionary histories. Copy number alterations are independently and reiteratively acquired in subclones of individual patients, and in no preferential order. Clonal architecture is dynamic and is subject to change in the lead-up to a diagnosis and in relapse. Leukaemia propagating cells, assayed by serial transplantation in NOD/SCID IL2Rγ(null) mice, are also genetically variegated, mirroring subclonal patterns, and vary in competitive regenerative capacity in vivo. These data have implications for cancer genomics and for the targeted therapy of cancer.

PubMed Disclaimer

Comment in

Similar articles

Cited by

References

    1. Nature. 2007 Mar 8;446(7132):153-8 - PubMed
    1. Science. 2008 Nov 28;322(5906):1377-80 - PubMed
    1. Nat Genet. 2006 Apr;38(4):468-73 - PubMed
    1. Clin Cancer Res. 2004 Aug 15;10(16):5355-60 - PubMed
    1. J Clin Invest. 2007 Nov;117(11):3155-63 - PubMed

Publication types

MeSH terms

Substances

Associated data